ÎÄÏ××ÊÁÏ
ÁªÏµ918²«ÌìÌÃ
918²«ÌìÌÃ
µç»°£º0570£8788056
´«Õ棺0570£8788381
ÓÊÏ䣺zjgykp@163.com
µØµã£ºÕã½Ê¡áéÖÝÊж«¸Û¾¼Ã¿ª·¢Çø
¶«¸Û4·2ºÅ
- ¹û½º¶àÌǽṹÓ뽵Ѫ֬Ñо¿½øÕ¹
- Ðû²¼Ê±¼ä£º 2019/2/20¡¡µã»÷´ÎÊý£º3550¡¡
-
¹û½º¶àÌǽṹÓ뽵Ѫ֬Ñо¿½øÕ¹
²ÌΪÈÙ1 £¬ËïÔªÁÕ2 £¬ÌÀ ¼á3
(1.°²»Õ¹¤³Ì¿Æ¼¼Ñ§ÔºÉú»¯Ïµ£¬°²»Õ Îߺþ 241000£»2.ɽÎ÷Ô˳ÇѧԺÉúÃü¿Æѧϵ£¬É½Î÷ ÔË³Ç 044000£»
3. ½ÄÏ´óѧ ʳƷ¿ÆѧÓë¼¼Êõ¹ú¼ÒÖصãʵÑéÊÒ£¬½ËÕ ÎÞÎý 214122)
רÌâÂÛÊö ʳƷ¿Æѧ 2010, Vol. 31, No. 05
Õª Òª£º¹û½ºÊÇÒ»Öֹ㷺±£´æÓÚÖ²Îïϸ°û±ÚÖеĶàÌÇÀà´ó·Ö×ÓÎïÖÊ£¬À´Ô´¸»ºñ£¬ÎÞ¶¾£¬ÊÇÖØÒªµÄʳƷÌí¼Ó¼ÁÖ®Ò»¡£ËæןßѪ֬ÈËȺµÄÔö¶à£¬¹û½º¶àÌǵ÷ÀíѪ֬µÄ¹¦Ð§½á¹¹ÈÕÒæÊܵ½¹Ø×¢¡£±¾ÎÄ×ÛÊö¹û½º¶àÌǵĽṹ¡¢µ¨¹Ì´¼ÎüÊÕ¡¢ µ¨ÖËáµÄÊø¸¿ÓëÅųö¡¢Ö¬ÂÑ°×´úл±ä¸ï¼°½á³¦½Í½âµÄÑо¿½øÕ¹£¬Îª¹û½º¶àÌǽµÑªÖ¬ÉúÎï»îÐÔ¼°¹¹Ð§¹ØϵµÄ½øÒ»²½Ñо¿Ìṩ²Î¿¼¡£
Òªº¦´Ê£º¹û½º¶àÌÇ£»½á¹¹£»½µÑªÖ¬£»Ñо¿½øÕ¹
¹û½ºÊÇÒÔÔ¹û½º¡¢¹û½º¡¢¹û½ºËáµÄÐÎ̬¹ã·ºÂþÑÜÓÚÖ²ÎïµÄ¹ûʵ¡¢¸ù¡¢¾¥¡¢Ò¶ÖеĶàÌÇÀà¸ß·Ö×Ó»¯ºÏÎ ÓëÏËάËØ¡¢°ëÏËάËØÏà°é£¬×é³ÉÖ²Îïϸ°û°û¼ä²ã(middlelamella)ºÍ³õÉú±Ú(primary wall)¡£Ëæ×ÅÈËÃÇÉú»îˮƽµÄÈÕÒæÌá¸ß£¬·ÊÅÖ¡¢¸ßѪѹÒÔ¼°¸ß֬Ѫ֢µÈһЩËùν¡°·±»ª²¡¡±µÄ·¢²¡ÂʳÊÖðÄêÉÏÉýÖ®ÊÆ£¬¼°Ë湦ЧÐÔ¶àÌǵĿª·¢Ñо¿£¬¹û½º¶àÌǼ°Æ併Ѫ֬¹¦Ð§µÄÑо¿Ô½À´Ô½Êܵ½Ñо¿ºÍ¼Ó¹¤ÐÐÒµµÄÖØÊÓ¡£¹û½º¶àÌǽṹÅÓ´ó£¬ÆäÉúÀí»îÐÔÓëÆä½á¹¹½ôÃÜÏà¹Ø£¬¸÷¹úѧÕß½øÐÐÁË´ó×ÚµÄÑо¿ÊÂÇ飬±¾Îľ͹û½º¶àÌǽṹÓëµ÷ÀíѪ֬¹¦Ð§×÷Ò»×ÛÊö¡£
1 ½á¹¹ºÍ»¯Ñ§×é³É
¾Í»¯Ñ§×é³ÉºÍÉúÎïºÏ³É¶øÂÛ£¬¹û½º¿ÉÄÜÊÇ×îÅÓ´óµÄÒ»Àà¶àÌÇ¡£¹û½ºÀà¶àÌÇ´ú±í¸ßµÈÖ²Îï³õ¼¶Ï¸°û±ÚºÍÏàÁÚ
ϸ°û¼ä½ôÃÜÁªºÏµÄÒ»×é¶àÌÇ£¬Ò²´ú±í´ÓÖ²ÎïÖÊÁÏÖƱ¸µÄÒ»ÀàÅÓ´ó½º×´¶à¾ÛÌ壬ϰ¹ß³ÆΪ¹û½ºÌÇÎïÖÊ¡£Æ仯ѧ½á¹¹ºÍ·Ö×ÓÁ¿ÓëÆäÖ²ÎïÀ´Ô´¡¢×éÖ¯²¿Î»¡¢³ÉÊì¶È¼°ÌáÈ¡ÒªÁìµÈÒòËØÓйء£ÔçÔÚ 1825 Ä꣬Raconnot Ê״δӺúÂܲ·ÖÐÌáÈ¡³öÒ»ÖÖË®ÈÜÐÔÎïÖÊ£¬¿ÉÐγÉÄý½º£¬²¢½«¸ÃÎïÖÊÃüÃûΪ¡°Pectin¡±(pectin Ô´ÓÚÏ£À°´Êpektos£¬ÓÐÄý¹Ì¡¢Äý½áÖ®Òâ) [1]¡£1944 Äê 4 ÔÂÃÀ¹ú»¯Ñ§»áÕýʽÐû²¼¡°¹û½ºÀàÎïÖʵÄÐÞ¶©Ãû³Æ¡±£¬¶ÔÆäʱ³£ÓõĹû½ºËá( p e c t i n
acid)¡¢¹û½º(pectin)ºÍÔ¹û½º(protopectin)Ãû´Ê»®·Ö»®¶¨Á˾۰ëÈéËáÈ©Ëá¡¢º¬ÓÐÖÐÐÔÌDzàÁ´ÇÒ²¿·Ö±»¼×õ¥»¯µÄ¹û½ºËá¡¢ÓëÏËάËغͰëÏËάËؽáºÏÔÚÒ»ÆðµÄ¼×õ¥»¯¾Û°ëÈéÌÇÈ©ËáÜյļÄÒå¡£Ëæ×Å¿Æѧ¼¼ÊõµÄÉú³¤£¬ÖÚ¶àѧÕßÔÚ¹û½º¶àÌÇÊèÉ¢´¿»¯¡¢¼×»ù»¯ÆÊÎö̼Á´½á¹¹ºÍËá»òøˮ½âµÈ·½Ãæ×öÁËÖÚ¶àÑо¿¡£È磬1955 ÄêBishop[ 2 ] ±¨µÀ£º²ÉÓòÝËá炙º³åÒºÌáÈ¡ÏòÈÕ¿ûÅ̶àÌÇ£¬ËữÒÒ´¼ÓëÏ¡¼î´¼³Á»®·ÖÖƵÃÆä¹û½ºÓë¶àÌÇ¡£Ö½²ãÎöʵÑéÏÔʾ£¬¸Ã¹û½º»ù±¾½á¹¹Îª¦Á(1 ¡ú 4)¼üºÏµÄD- °ëÈéÌÇÈ©Ëᣬ¶àÌÇÓÉ°ëÈéÌÇ¡¢ÆÏÌÑÌǺÍÉÙÁ¿°¢À²®ÌÇ×é³É¡£1965 Ä꣬Zitko µÈ[ 3 ] ´ÓÏòÈÕ¿û¡¢Ìð²Ë¡¢Æ»¹ûºÍ¸ÌéÙÊèÉ¢³ö¹û½ºËᣬµçӾʵÑéÏÔʾÕâЩ¹û½ºËá¾ùÓÉÓÎÀë¾Û°ëÈéÌÇÈ©ËáÌǺÍÖ§Á´¼üºÏ¾Û°ëÈéÌÇÈ©ËáÌÇÁ½²¿·Ö×é³É¡£·¢Ã÷ÔÚÆ»¹û[ 4 ] ¡¢ÜÙÞ£[ 5 ] ¡¢¶¹¼Ô[6]ÖÐÓÉ°ëÈéÌÇÈ©Ëá(1¡ú2)ÊóÀîÌÇ×é³ÉµÄ¾ÛÊóÀî°ëÈéÌÇÈ©ËẬÁ¿½Ï¸ß¡£1973 Ä꣬Talmadge µÈ[ 7] ´ÓÎÞ»¨¹ûƤÌáÈ¡´¿»¯¾ÛÊóÀî°ëÈéÌÇÈ©ËᣬΪÖÆÖ¹Ëá¶ÔÌÇÜÕ¼üÓвî±ðˮƽµÄË®½â¡¢¹ý¸ßµÄ¼îŨ¶È»áÓÉÓÚ±¬·¢ÍÑõ¥ºÍ¦Â - ÏûÈ¥·´Ó¦µÄÓ°Ï죬½ÓÄÉÄÚÇо۰ëÈéÌÇÈ©Ëáøˮ½â£¬ÊͷųöÖÖÖÖ¶àÌÇƬ¶Î£¬¼×»ù»¯ºóµ¥ÌÇÈ©´¼ÒÒËáõ¥ÖÊÆ×ÆÊÎö±êÃ÷£º ÊóÀî°ëÈéÌÇÈ©Ëá¾ÛÌÇÖ÷Òª³ÊÊóÀîÌÇ-(1 ¡ú 4)- °ëÈéÌÇÈ©Ëá(1 ¡ú 2)ÊóÀîÌÇ̼Á´½á¹¹¡£1978 Ä꣬Darvill µÈ[8]Óøߴ¿µÄÄÚÇо۰ëÈéÌÇÈ©Ëáøˮ½â 7 ÖÖÐüÁåľϸ°û£¬Äý½ºÉ«Öù´¿»¯»ñµÃµÄÊóÀî°ëÈéÌÇÈ©Ëá¾ÛÌÇ - ¢ò - ( R h a m n o - galacturonans II£¬RG- ¢ò)º¬Á¿Ïà½ü£¬RG- ¢òÓÉ°ëÈéÌÇÈ©Ëá(GalA)¡¢ÊóÀîÌÇ(Rha)¡¢°¢À²®ÌÇ(Ara)¡¢°ëÈéÌÇ(Gal) µÈ 10 ÖÖÌDzлù×é³É£»ÊóÀîÌDzлùÒÔ 2 ,4 ÌÇÜÕ¼üÁ¬½ÓÔÚD- °ëÈéÌÇÈ©Ëá²Ð»ùÐγÉÖ÷Á´£»²àÁ´ÉÏÖ÷Òªº¬ L- °¢À²®ÌÇºÍ D- °ëÈéÌDzлù¡£1997 Ä꣬Renard µÈ[9 ]½øÒ»²½Ó¦ÓÃHPLC É«Æ׺Í1 H NMR ÆÊÎöÁËÖÖÖÖ¶àÌÇËéƬ£¬Ö¤ÊµÁËÒÔÉÏÍƲ⡣һ¸ö°ëÊÀ¼ÍÒÔÀ´£¬ÖÚ¶à¿Æѧ¼ÒÔÚ¹û½º¶àÌÇÁìÓò½øÐÐ×ÅϸÖ¶øÉîÈëµÄÑо¿£¬Ê¹¹û½º¶àÌǵĽṹ¡¢»¯Ñ§×é³ÉÔ½À´Ô½Ç÷ÓÚϵͳºÍÍêÉÆ¡£
¹û½º¶àÌǵķÖ×ÓÁ¿½éÓÚ 10000¡«400000D Ö®¼ä£¬Æä·Ö×ӽṹ·ÖΪƽ»¬ÇøÓëë·¢Çø£ºÆ½»¬ÇøÓɦÁ -D- °ëÈéÌÇÈ©Ëá²Ð»ùͨ¹ý 1,4 ÌÇÜÕ¼üÏßÐÎÁ¬½Ó£»Ã«·¢ÇøÓɸ߶ȷÖÖ§µÄ¦Á - L - ÊóÀî°ëÈéÌÇÈ©Ëá×é³É¡£Òò´Ë£¬Æ¾¾Ý½á¹¹·ÖÀ࣬ ¹û ½ºÀà¶àÌÇ°üÀ¨ 3 ´óÀà £º °ëÈéÌÇÈ©Ëá¾ÛÌÇ (homogalacturonans£¬HGA)¡¢ÊóÀî°ëÈéÌÇÈ©Ëá¾ÛÌÇ- ¢ñ(rhamnogalacturonans I£¬RG- ¢ñ)ºÍÊóÀî°ëÈéÌÇÈ©Ëá¾ÛÌÇ- ¢ò¡£
1.1 °ëÈéÌÇÈ©Ëá¾ÛÌÇ(HGA)
HGAÊÇÓɦÁ-D- °ëÈéÌÇÈ©Ëá²Ð»ùͨ¹ý1,4 ÌÇÜÕ¼üÁ¬½Ó¶ø³ÉµÄÏßÐÔÌÇÁ´£¬ÓÉ 100¡«500 ¸öGalA ²Ð»ù×é³É¡£ÆäÖаëÈéÌÇÈ©ËáµÄôÈ»ùÓвî±ðˮƽµÄ¼×õ¥»¯£¬Òò´ËÌìÈ»¹û½º·ÖΪ¸ß¼×Ñõ»ù¹û½º(HM)ºÍµÍ¼×Ñõ»ù¹û½º(LM)¡£Î´¼×õ¥»¯µÄôÈ»ùÔòÒÔÓÎÀëËáÐÎʽ»òÒÔK¡¢Na¡¢Ca ÑεÈÐÎʽ±£´æ¡£HM ¹û½ºÔÚÓÐ×ã¹»µÄÌÇŨ¶ÈºÍËáÌõ¼þϲŻªÐγÉÄý½º£»LM ¹û½ºÔÚCa2+ ±£´æʱͨ¹ý°ëÈéÌÇÈ©ËáÁ´ÓëCa2+ ½»Áª±¬·¢·Ö×Ó¼äµÞºÏ¶øÐγÉÄý½º(ͼ 1)[10]¡£ÓеÄGalA µÄC2 »òC 3 λôÇ»ù»¹±¬·¢ÒÒõ£»¯¡£
1.2 ÊóÀî°ëÈéÌÇÈ©Ëá¾ÛÌÇ- ¢ñ(RG- ¢ñ)
¹û½º¶àÌÇͨ³£ÎªÔÓ¶àÌÇ£¬³£ÔÚ¦Á -(1 ¡ú 4)Á¬½ÓµÄ¶à¾Û°ëÈéÌÇÈ©ËáÖ÷Á´Öмä²åÈëßÁà«ÐÍÊóÀîÌÇ(Rhap)£¬ÐγɰëÈéÌÇÈ©ËáºÍÊóÀîÌǽ»Ìæ×é³ÉµÄÖظ´µ¥Î»£º4 )- ¦Á - D - GalpA-(1,2)- ¦Á -L-Rhap-(1£¬¼´ÎªRG- ¢ñ(ͼ 2)[11]¡£ÔÚÊóÀîÌDzлùµÄC4 λ½áºÏÓвî±ðÖÖÀàµÄÖÐÐÔ»òËáÐԹѾÛÌÇ£º
1)°¢À²®°ëÈé¾ÛÌÇ(arabinogalactans)ÒԦ -(1 ¡ú 4)Á¬½ÓµÄ¶à¾Û°ëÈéÌÇΪÖ÷Á´²¢´øÓЦÁ -(1 ¡ú 5)L- °¢À²®ß»à«ÌDzлù(Araf)²àÁ´£»2)°ëÈé¾ÛÌÇ(galactan)ÊǸ߶ȷÖÖ§µÄ¶àÌÇ£¬
ͼ 1 LM¡°µ°ºÐ¡±½ºÄýÄ£ÐÍ
Fig.1 Schematic egg box model of calcium binding to low-methoxyl pectin
Óɦ -D- ßÁà«°ëÈéÌDzлùÒÔ 1,3 ºÍ 1,6 ¼üÏ໥Á¬½Ó¶ø³É£»
3)°¢À²®¾ÛÌÇ(arabinan)ÓÉ L- °¢À²®ÌDzлùÒÔ 1,5 ¼üÁ¬½Ó, ²¢½ÓÓÐ 1 , 3 ·ÖÖ§¡£±ðµÄ£¬Ã«·¢ÇøµÄ²àÁ´Ä©¶Ë»¹·¢Ã÷ÓЦÁ -L- ¹ûÌDzлù(Fucp)£¬¦Â -D- ÆÏÌÑÌÇÈ©Ëá²Ð»ù(GlcpA)£¬ ÒÔ¼°4-O- ¼×»ù- ¦Â-D- ÆÏÌÑÌÇÈ©Ëá²Ð»ù(4-O-Me GlcpA)µÈ¡£
1.3 ÊóÀî°ëÈéÌÇÈ©Ëá¾ÛÌÇ-II(RG-II)
RG-IIÊÇËùÓиߵÈÖ²ÎïµÄϸ°û±ÚÖоùº¬ÓеÄÒ»ÖÖËáÐÔ¹û½º£¬Æä½á¹¹ÌØÕ÷ÊÇÖ÷Á´Îª¾ù¾Û°ëÈéÌÇÈ©Ëᣬ²àÁ´º¬ÓÐ 4 ÖֽṹÅÓ´óµÄ¹ÑÌÇ(ͼ 3)¡£Óëϸ°û±ÚÖеÄÅðÐγɸ´ºÏÎ¼ÓÈëÅðµÄÔËÊä[12]¡£RG-II ¶àÌÇÄÜÓëǦÀë×Ó÷¡ºÏ£¬¾ßÓнⶾÓëÃâÒßµ÷Àí»îÐÔ[13]¡£Nergard µÈ[14] Ñо¿±êÃ÷£¬´Ó°ßð¯¾ÕµÄ¸ùÖÐÌáÈ¡µÄº¬ÓÐRG- II ½á¹¹µÄËáÐÔ¹û½ºÎïÖÊ£¬ ¾ßÓв¹ÌåÐÞ¸´ÒÔ¼°Ôö½øB ÓëT ϸ°ûÉú³¤»îÐÔ¡£
2 ¹û½º¶àÌǵ÷ÀíѪ֬»úÀí
ÔçÔÚ 20 ÊÀ¼Í 60 Äê´ú£¬ÔÚÈ˺ʹóÊóµÄÑо¿ÖоÍÒÑ·¢ÏÖ¹û½º¶àÌÇÄܽµµÍѪÇ嵨¹Ì´¼Ë®Æ½[16- 17 ]£¬½ñºó£¬ÔÚµ¨¹Ì´¼µÄÏû»¯¡¢ÎüÊÕ¡¢×ªÔ˵ȷ½Ã濪չÁËÓйعû½º¶àÌǽµµÍѪÇ嵨¹Ì´¼µÄÑо¿¡£
2.1 ¹û½º¶àÌǶԵ¨¹Ì´¼ÎüÊÕµÄÓ°Ïì
»úÌåÄڵĵ¨¹Ì´¼Ö÷ÒªÓÐÁ½ÖÖÀ´Ô´£¬Ò»ÖÖÊdz¦µÀÄÚÎüÊÕµÄÉÅʳµ¨¹Ì´¼¡¢µ¨¹Ì´¼õ¥ºÍµ¨ÖÖеĵ¨¹Ì´¼£¬ÁíÒ»ÖÖÊǸÎÔàºÍÍâÖÜ×éÖ¯Öб¬·¢µÄµ¨¹Ì´¼¡£ÒûʳÖе¨¹Ì´¼õ¥ÔÚÒÈÏÙÅÅйµÄµ¨¹Ì´¼õ¥Ã¸Ë®½âÏÂÉú³Éµ¨¹Ì´¼£¬Ó뵨ÖËá¡¢Á×Ö¬¡¢¸ÊÓÍÖ¬Ò»Æð×é³É»ìÏý΢ÍÅ£¬ÎüÈëð¤Ä¤Ï¸°û£¬ ÔÚÄÚÖÊÍøÄÚÐγÉÈéÃÓ΢Á££¬¾ÁÜ°Íϵͳ½øÈëѪҺÍê³ÉÏû»¯ÎüÊÕ¡£¹û½ºÎüË®ÐÔÇ¿ÇÒÄÑÏû»¯£¬´Ó¶ø¿É³äÔ£³¦Î¸¡£µ« ¶ÔÒÈÏÙÅÅй½öÓкÜСӰÏì[18 ]¡£Jacobs[19 ]ÈÏΪ¹û½º»áÔö¼ÓÈÞëϸ°ûµÄÍÑÂä¡£Kelley µÈ[20]½ÓÄÉ14C ±ê¼Çµ¨¹Ì´¼,¿¼²ì½á¹ûÏÔʾ£¬ÉãÈë¹û½º¡¢¹Ï¶û½º¡¢³µÇ°×Ó½º¾ù¿Éʹ¸ÎÖе¨¹Ì´¼ÎüÊÕϽµ£¬½ö¹û½º¿ÉʹѪ½¬µ¨¹Ì´¼ÎüÊÕϽµ¡£´ó¶¼Ñ§ÕßÈÏΪ£¬¹û½º¾ßÓÐÄý½ºÌØÐÔ£¬Ó°Ï쵨¹Ì´¼ÓëÏû»¯Ã¸¡¢µ¨ÖËá΢Íż°³¦ð¤Ä¤µÄ½Ó´¥£¬Í¬Ê±Êø¸¿µ¨ËᣬÔì³ÉÖ¬ÖÊÈ黯ÕÏ°[ 2 1 ] £¬¼õÂý³¦ÏµÄ¤µÄÁÜ°ÍÑ»·¼°µ¨ÖÔÙÑ»·¡£
2.2 ¹û½º¶àÌǶԵ¨ÖËáµÄÊø¸¿ÓëÅųöµÄÓ°Ïì
µ¨ÖËáÔÚ¸ÎÔàÖÐÓɵ¨¹Ì´¼ºÏ³Éºó¾³¦¸ÎÑ»·ÅÅÈëÊ®¶þÖ¸³¦£¬Î¬³ÖÈËÌå¶ÔÖ¬ÖÊÎïÖʵÄÏû»¯ÎüÊÕ¡£Õý³£Çé¿öÏ£¬´ó²¿·Öµ¨ÖËáÔÚС³¦Öо¸Î³¦Ñ»·ÖØÎüÊÕ½øÈë¸ÎÔ࣬´Ó¶øʹµ¨ÖËá¼á³ÖÎȶ¨¡£¹û½ºÊø¸¿µ¨ÖËá¡¢Ôö½øÆäÅųö£¬Í¨¹ý¸ÎÄÚµ¨¹Ì´¼³Øƽºâ£¬Å²ÓÃѪ½¬µ¨¹Ì´¼£¬ ´Ó¶øÆðµ½½µµ¨¹Ì´¼µÄ×÷Óá£
1990 Ä꣬ÃÀ¹úFernandez µÈ[22]±¨µÀ£¬µ¨¹Ì´¼ËÇÁϼÓ1% ÏÉÈËÕƹû½º£¬Î¹Ñø¼¸ÄÚÑÇÖí 25d£¬Ñª½¬µÍÃܶÈÖ¬µ°°×µ¨¹Ì´¼(LDL-C)Ͻµ 33%£¬¸Îϸ°û΢Á£ÌåµÄ 3- ôÇ»ù-3- ¼×»ùÎì¶þõ£¸¨Ã¸A »¹Ôø(µ¨¹Ì´¼ºÏ³ÉÏÞËÙø)Ũ¶ÈûÓбä¸ï£¬ÓÎÀ뵨¹Ì´¼Ó뵨¹Ì´¼õ¥»®·ÖϽµ 40 % Óë 8 5 %¡£Ìí¼Ó¹û½º( 1 2 . 5 %) µ½µÍ¡¢¸ßµ¨¹Ì´¼ËÇÁÏÖУ¬¿Éʹ¸ÎÄÚ7¦Á - ôÇ»¯Ã¸(µ¨ÖËáºÏ³ÉÏÞËÙø)»îÐÔ»®·ÖÉϵ÷3±¶ºÍ5±¶[23]¡£½á¹ûÏÔʾ¹û½ºÏµ÷Ѫ½¬µ¨¹Ì´¼µÄ;¾¶£¬ÀàËÆÓÚµ¨ÖËá½áºÏÊ÷Ö¬¡£
¹û½º¶ÔÖ¬ÖÊ´úлµÄ×÷Óã¬ÓëÆä½á¹¹¡¢ð¤¶È¡¢ÑôÀë×Ó½»»»ÌØÐÔ¼°Ïû»¯µÀÄÚµÄÅÅйÎï±ä¸ïÓйء£Terpstra µÈ±¨µÀ£ºÌí¼Ó¸ßð¤¶È¸ÆÃô¸ÐµÄ¹û½º( DE£¬69 %)¡¢µÍð¤¶È¸Æ²»Ãô¸ÐµÄ¹û½º( DE£¬34 %)¡¢¸ßð¤¶È¹Ï¶û¶¹½º¡¢µÍð¤¶È¹Ï¶û¶¹½ººÍ³µÇ°×Ó½ºÓÚËÇÁÏÖУ¬´óÊó 8 ÖÜιÑøºó½á¹ûÏÔʾ£º ¸ßð¤¶È¹û½ºÊµÑéÊóÖÐѪ½¬µ¨¹Ì´¼õ¥×ªÔËÂÑ°×(CETP)»îÐԱȵÍð¤¶È¹û½ºÏÔÖøϽµ£»·à±ãÖе¨ÖËáºÍÖÐÐÔçÞ´¼Ôö¶à[ 24 ]£»¶øÌí¼Ó 8% ³µÇ°×Ó½º£¬¸ÎÖÐ×ܵ¨¹Ì´¼ºÍµ¨¹Ì´¼õ¥±È¹û½º×éÓÐÏÔÖøϽµ£¬·à±ãÁ¿Ôö¼Ó 9 0 %£¬µ¨(Ëá) ÑΡ¢¶ìÍÑÑõµ¨( Ëá) ÑΡ¢¸Ê°±ËáºÍÅ£»ÇËẬÁ¿ÏÔÖøÌá¸ß[ 25 ] ¡£Ìáʾ¹û½ºÓ복ǰ×Ó½º½µÑªÖ¬»úÖÆÓвî±ðÖ®´¦¡£
2.3 ¹û½º¶àÌǶÔÖ¬ÂÑ°×´úлµ÷¿ØµÄÓ°Ïì
ABCA1 ºÍATP Ϊ½áºÏתÔËÂÑ°×£»ACAT Ϊ֬·¾õ£- µ¨¹Ì´¼õ£»ùתÒÆø£»CETP Ϊµ¨¹Ì´¼õ¥×ªÔËÂÑ°×£» CE Ϊµ¨¹Ì´¼õ¥£» CM ΪÃÓÈé΢Á££»CR ΪʣÓà¿ÅÁ££»HL Ϊ¸ÎÖ¬·¾Ã¸£»LDL-R ΪLDL ÊÜÌ壻Ch Ϊµ¨¹Ì´¼£» SR-B1 ΪÇåµÀ·òÊÜÌå-B1¡£
ͼ 4 µ¨¹Ì´¼¼°ÔØÖ¬ÂÑ°×תÔËʾÒâͼ
Fig.4 Schematic diagram of cholesterol and lipoprotein metabo- lism
20 ÊÀ¼Í³õ´ó×ÚµÄÁ÷Ðв¡Ñ§Ñо¿·¢Ã÷Ѫ½¬µ¨¹Ì´¼(TC) ˮƽ¡¢¸ÊÓÍÈýõ¥(TG) Óë¹ÚÐIJ¡µÄ²¡ËÀÂÊÃÜÇÐÏà¹Ø¡£90 Äê´úͨ¹ý¶ÔÖ¬ÖÊ£¬ÓÈÆäÊÇÖ¬ÂÑ°×µÄÑо¿ÏÔʾ£¬ LDL-C Ôö¸ßÔö½ø¶¯ÂöÖàÑùÓ²»¯£¬¸ßÃܶÈÖ¬ÂÑ°×- µ¨¹Ì´¼(HDL-C) Ôö¸ßÔòÓбÜÃ⶯ÂöÖàÑùÓ²»¯×÷Óá£HDL- C ÊÓΪ¡°ºÃµÄµ¨¹Ì´¼ ¡±¡£
Fernandez µÈ[22 ]Ñо¿±¨µÀ£¬ÉãÈë¹û½º¡¢¹Ï¶û½º¡¢³µÇ°×Ó½ººó£¬Ñª½¬µ¨¹Ì´¼ÏÔÖøϽµ£»¼«µÍÖ¬ÂÑ°×(VLDL) ÖÐTG ºÍÁ×Ö¬º¬Á¿Ôö¼Ó£¬ÌåÏÖÓÐÐÂÉúµÄVLDL Éú³É£»ÂÑÁ×Ö¬µ¨¹Ì´¼Ö¬õ£×ªÒÆø(LCAT)ºÍCETP »îÐÔϽµ£»·ÅÉäÐÔ±ê¼ÇVLDL²âµÃVLDLתÔ˸ü¿ì¡¢LDL-apoB ÍâÁ÷Ìá¸ß£¬ ±êÃ÷¹û½ºµÈÎïÖʵÄÉãÈë¿ÉÉϵ÷LDL ÊÜÌå¡£Brown µÈ[26]½øÒ»²½Ñо¿Ö¸³ö£¬ÉãÈëÿ¿Ë¹û½º¿É»®·Öϵ÷×ܵ¨¹Ì´¼ºÍµÍÃܶÈÖ¬ÂÑ°×µ¨¹Ì´¼Ô¼ 0.070mmol/L ºÍ 0.055mmol/L¡£
½ü´úҽѧÑо¿ÏÔʾ£¬ÇåµÀ·òÊÜÌå-B1(SR-B1)ºÍÏÙÈýÁ×½áºÏºÐתÔËÌåA1(ABCA1)Ôڽ鵼ϸ°ûÄÚµ¨¹Ì´¼Á÷³öÖз¢»ÓÖØÒª×÷ÓÃ[27](ͼ4)¡£SR-B1 ½éµ¼µÄ¸ÎÔà¿É´ÓHDL Ñ¡ÔñÐÔÉãÈ¡µ¨¹Ì´¼¡£ÆäÖÐapo A ¢ñÊÇ HDL ×îÖ÷ÒªµÄÂÑ°×Éí·Ö£¬Óë¸ßÃܶÈÖ¬ÂѰ׿ÅÁ£µÄÐγÉÓйأ»ÊÇÂÑÁ×Ö¬µ¨¹Ì´¼õ£»ùתÒÆø(LCAT)µÄÖ÷Òª¼¤»î¼Á¡£HDL ¿É½«Ðî»ýÓÚÄ©ÉÒ×éÖ¯µÄÓÎÀ뵨¹Ì´¼ÓëѪѻ·ÖеÄÖ¬ÂÑ°×»òijЩ´ó·Ö×Ó½áºÏ£¬ÔËÊäµ½¸ÎÔ࣬½øÐе¨¹Ì´¼µÄÄæתÔË¡£A B C A 1 ÊÇÔØÖ¬ÂѰ׽鵼µÄÖ¬ÖÊÄæתÔËͨ·ÖеÄÏÞËÙÂÑ°×ÖÊ£¬×ªÂ¼ºóµÄµ÷Àí¿Éͨ¹ýÓëapoA ¢ñµÄ½áºÏÀ´ÊµÏÖ¡£ÏÖÒÑÖªµ¨¹Ì´¼¡¢acLDL¡¢oxLDL µÈ¶à¸öÒòËØ¿ÉÒÔµ÷Àí ABCA1 µÄ»îÐÔ[ 2 8 ] ¡£
ÀîïÑÔµÈ[29]Ñо¿ÁËÜñ½Õ¹û½º¶Ô¸ß֬Ѫ֢´óÊóµ÷Ö¬×÷Ó㬽á¹ûÏÔʾÜñ½Õ¹û½º³Ê¼ÁÁ¿ÒÀÀµÐÔµØÃ÷ÏÔ½µµÍ¸Îµ¨¹Ì´¼¡¢TC¡¢LDL-C£¬¸ßÃܶÈÖ¬ÂÑ°×ÑÇ×é·Ö3 µ¨¹Ì´¼(HDL3-C) ¼°ÑªÇåTG µÄº¬Á¿¡£¿ÉÃ÷ÏÔÌá¸ß¸ßÃܶÈÖ¬ÂÑ°×ÑÇ×é·Ö2 µ¨¹Ì´¼(HDL2-C) µÄº¬Á¿¡£
±ðµÄ£¬¹Ï¶û¶¹½º¡¢Ìð²Ë¶àÌÇ¿ÉÉϵ÷LDL ÊÜÌåºÍϵ÷SR-B1 »îÐÔ[30-31]¡£
2.4 ¹û½º¶àÌǶԽ᳦·¢½Í×÷ÓõÄÓ°Ïì
»úÌå×Ô¼º²»ÅÅй½µ½â¹û½ºµÄø£¬¹û½º¿É±»´ó³¦ÄÚµÄ Î¢ÉúÎï·¢½Í½µ½â£¬±¬·¢¶ÌÁ´Ö¬·¾Ëá( SCFA)£¬ºó¾ÃÅÂöϵͳ½øÈë¸ÎÔà´úл¡£Gulfi µÈ±¨µÀ¹û½ºµÄ·Ö×ÓÁ¿ºÍð¤¶È²¢²»Ó°ÏìÆä½Í½âÐÔ£¬¸ß¼×Ñõ»ù¹û½º±¬·¢µÄSCFA Á¿ÉԶ࣬ ¸ß¼×Ñõ»ù¹û½ºÍêÈ«½Í½âʱ¼ä¶Ì£¬µÍ¼×Ñõ»ù¹û½ºÍêÈ«½Í½âʱ¼ä³¤[32 ]£¬³¦¾ú¶Ô¹û½º´úлµÄÖ÷ÒªÖÕÄ©²úÆ·ÊÇÒÒËá¡¢±ûËá¡¢¶¡Ëá¡¢¶þÑõ»¯Ì¼¡¢¼×Íé¡¢ÇâÆøºÍË®¡£¿ÉÈÜÐÔÏËά¹û½ºÉú³ÉÒÒËá¡¢±ûËá¡¢¶¡ËáµÄ±ÈÀýԼΪ 80 : 12 : 8 [ 3 3 ] ¡£ÒÒËá¡¢±ûËá¡¢¶¡Ëá±»½á³¦ð¤Ä¤ÉÏƤϸ°ûÎüÊÕ¡£¹û½ºÃ«·¢ÇøÉú³É±ûËá±ÈÀý±È°¢À²®½º¡¢µÍ¼×Ñõ»ùÆ»¹û¹û½º¡¢¸ß¼×Ñõ»ùÆ»¹û¹û½º¸ß[34 ]¡£¶¯ÎïʵÑé±êÃ÷£¬±ûËáÑοÉʹѪ½¬
µ¨¹Ì´¼Ë®Æ½Ï½µ[35]£»ÒÒËáÑÎÒÖÖƸÎÄÚµ¨¹Ì´¼µÄºÏ³É£¬²¢
ʹѪ½¬µ¨¹Ì´¼Ïò¸ÎÄÚתÒÆ[36]¡£Ò²ÓÐÈËÈÏΪ½Í½âÔö¼ÓÁË´ó³¦ÄÚϸ¾úµÄ»îÐÔ£¬Ê¹µ¨ÖËáÀëÉ¢£¬²»Ò×±»½á³¦ð¤Ä¤ÎüÊÕ¶ø±»Åųö£¬µ¼ÖÂÖØкϳɵ¨¹Ì´¼À´Ôö²¹µ¨ÖËá[ 3 7 ] ¡£
×ÛÉÏËùÊö£¬¹û½º¶àÌÇÊÇͨ¹ý½µµÍµ¨¹Ì´¼ÎüÊÕ¡¢Ôö½øµ¨ÖËáµÄÊø¸¿ÓëÅųö¡¢Éϵ÷LD L ÊÜÌå¡¢¼ÓËÙÔØÖ¬ÂÑ°×תÔ˺ͽ᳦·¢½Í×÷Ó㬶à;¾¶µ÷¿Ø»úÌåÄÚµ¨¹Ì´¼¼°¸ÊÓÍÈýõ¥º¬Á¿¡£ÓÉÓÚ¹û½º¶àÌǽṹÅÓ´óÐÔ£¬½ºÄýÐÔ¡¢½á³¦·¢½Íˮƽ¾ù²î±ð¡£Æä²úÆ·¶Ôµ¨¹Ì´¼´úл¡¢²ÐÔü¶Ôµ¨ÖËáÊø¸¿¡¢ÒÔ¼°»úÌ峦µÀ¾ú¡¢ÒæÉú¾úÓ볦µÀÈ䶯µÈÖî¶àÒòËØÏ໥ӰÏ죬¹û½º¶àÌǽµÑªÖ¬µÄÁ¿Ð§¹ØϵÉÐÐè½øÒ»²½Ñо¿¡£
3 ½á Óï
½ü 20 ÄêÀ´£¬Åãͬ×ÅÉú»î½Ú×àµÄ¼ÓËÙ¡¢Òûʳ½á¹¹µÄ¸Ä±ä£¬ÈËÃÇÌåÁ¦Ô˶¯µÄ¼õÉÙ£¬¸ßѪ֢֬³ÉΪÍþвÈËÀàÉúÃü½¡¿µµÄ³£¼û²¡¡¢¶à·¢²¡¡£ÎÒ¹úµ÷ÀíѪ֬±£½¡Ê³Æ·Êг¡ÔøÒ»¶ÈÔÓÂÒ£¬Á¼Ý¬²»Æ롣ȷ¶¨¹¦Ð§Òò×Ӻ͹¹Ð§¡¢Á¿Ð§¹ØϵµÄµÚ¶þ²úÆ·½ÏÉÙ¡£¹û½º¶àÌÇ×ÊÔ´¸»ºñ£¬¶Ô»úÌåÎÞ¸±×÷Óã¬ÔÚʳƷ¼°Ò½Ò©¹¤ÒµÓ¦Óù㷺¡£¹û½º¶àÌǽµÑªÖ¬»úÀíÆ«ÖØÓÚµ¨ÖËáµÄÊø¸¿ÓëÅųö£¬½øÒ»²½¿ªÕ¹¹û½º¶àÌǽṹÓë×÷ÓûúÀíµÄÑо¿£¬¿ÉΪ½µÑªÖ¬¶àÌǵĿª·¢Ìṩ²Î¿¼¡£
Research Progress in Structure and Hypolipidmic Mechanisms of Pectic Polysaccharides
CAI Wei-rong1£¬SUN Yuan-lin2£¬TANG Jian3
(1. Department of Biochemistry, Anhui College of Technology and Science, Wuhu 241000, China£»
2. Department of Life Sciences, Yuncheng University, Yuncheng 044000, China £»
3. State Key Laboratory of Food Science and Technology, Jiangnan University, Wuxi 214122, China)
Abstract £ºPectin is complex polysaccharides in cell walls of all plants. It is one of the most important food additives due to its abundant source and safety. Increasing attention has been paid to using pectic polysaccharides for the hypolipidemic function because of increasing number of hyperlipidemic patients. In this paper, the structure of pectic polysaccharides, and the effects of pectic polysaccharides on cholesterol absorption, bile acid chelation and secretion, plasma lipoprotein cholesterol metabolism and colon glycolysis are reviewed. All of these investigations will provide a reference to further explore structure-activity relationship of pectic polysaccharides on hypolipidemic function.
Key words£ºpectic polysaccharide£»structure£»antihyperlipidemia£»research progress
ÖÐͼ·ÖÀàºÅ£º O636.1 ÎÄÏ×±êʶÂ룺A ÎÄÕ±àºÅ£º1002-6630(2010)05-0307-05
- ÉÏһƪ£ºµÍ·Ö×Ӹ̽۹û½º·Û¶ÔÌÇÄò²¡Ð¡ÊóѪÌÇ¡¢ÑªÖ¬µÄµ÷Àí×÷ÓÃ
ÏÂһƪ£º - ·µ»ØÐÂÎÅÁбí